PapersFlow Research Brief
Celiac Disease Research and Management
Research Guide
What is Celiac Disease Research and Management?
Celiac Disease Research and Management is the study of diagnosis, management, prevalence, genetic variants, autoimmune mechanisms, intestinal permeability, histopathology, and nutritional deficiencies associated with celiac disease and gluten sensitivity.
This field encompasses 49,793 published works on celiac disease. Research covers diagnosis via serological markers like tissue transglutaminase, management through gluten-free diets, and genetic factors linked to autoimmune responses. Key studies address prevalence in at-risk and general populations, with guidelines standardizing pediatric diagnosis.
Topic Hierarchy
Research Sub-Topics
Celiac Disease Genetics
This sub-topic explores genetic risk factors, HLA associations, and genome-wide association studies in celiac disease. Researchers identify susceptibility loci, gene-environment interactions, and polygenic risk scores.
Tissue Transglutaminase Autoimmunity
This sub-topic focuses on tissue transglutaminase (tTG) as the primary autoantigen in celiac disease pathogenesis. Researchers study deamidation of gliadin peptides, antibody production, and immune tolerance mechanisms.
Celiac Disease Diagnosis
This sub-topic covers serological testing, biopsy histopathology, and non-invasive diagnostic guidelines for celiac disease. Researchers validate biomarkers, assess diagnostic accuracy, and develop pediatric protocols.
Gluten Sensitivity Spectrum
This sub-topic investigates non-celiac gluten sensitivity, wheat allergy, and irritable bowel syndrome overlaps with celiac disease. Researchers characterize clinical phenotypes, biomarkers, and immune responses.
Celiac Disease Management
This sub-topic addresses gluten-free diet adherence, nutritional rehabilitation, and emerging pharmacological therapies. Researchers evaluate compliance tools, micronutrient deficiencies, and enzyme therapies.
Why It Matters
Celiac disease research enables accurate diagnosis and management, reducing risks of nutritional deficiencies and associated autoimmune conditions. "Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study" by Fasano et al. (2003) found celiac disease occurs frequently in symptomatic patients, first- and second-degree relatives, and those with common disorders even without gastrointestinal symptoms, with prevalence in not-at-risk groups indicating widespread underdiagnosis. "European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease" by Husby et al. (2011) updated diagnostic criteria using tissue transglutaminase as the autoantigen, improving pediatric case identification and long-term management. "Identification of tissue transglutaminase as the autoantigen of celiac disease" by Dieterich et al. (1997) identified this key marker, facilitating serological testing that supports gluten-free diet adherence and prevents intestinal damage in affected individuals.
Reading Guide
Where to Start
"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease" by Husby et al. (2011), as it provides clear, updated diagnostic criteria incorporating tissue transglutaminase testing, serving as an accessible entry to clinical standards.
Key Papers Explained
"Identification of tissue transglutaminase as the autoantigen of celiac disease" by Dieterich et al. (1997) established the key serological marker, which Husby et al. (2011) incorporated into ESPGHAN guidelines for diagnosis. Fasano et al. (2003) built on this by quantifying prevalence using these markers in US populations, while Marsh (1992) connected gluten structures to MHC-driven pathology underlying the autoantigen response. Green et al. (2006) and Holmes and Cooke (1984) synthesize these into management overviews.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues to explore genetic architectures from studies like Jostins et al. (2012) on host-microbe interactions in inflammatory bowel disease, with potential overlaps to celiac genetics. Type 1 diabetes loci from Barrett et al. (2009) suggest shared autoimmune pathways needing further celiac-specific validation.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Host–microbe interactions have shaped the genetic architecture... | 2012 | Nature | 4.8K | ✓ |
| 2 | The immune dysregulation, polyendocrinopathy, enteropathy, X-l... | 2001 | Nature Genetics | 3.3K | ✕ |
| 3 | Vedolizumab as Induction and Maintenance Therapy for Ulcerativ... | 2013 | New England Journal of... | 2.8K | ✓ |
| 4 | Coeliac Disease | 1984 | — | 2.7K | ✕ |
| 5 | European Society for Pediatric Gastroenterology, Hepatology, a... | 2011 | Journal of Pediatric G... | 2.6K | ✓ |
| 6 | Celiac Disease | 2006 | — | 2.5K | ✕ |
| 7 | Identification of tissue transglutaminase as the autoantigen o... | 1997 | Nature Medicine | 2.0K | ✕ |
| 8 | Gluten, major histocompatibility complex, and the small intest... | 1992 | PubMed | 2.0K | ✕ |
| 9 | Genome-wide association study and meta-analysis find that over... | 2009 | Nature Genetics | 1.8K | ✓ |
| 10 | Prevalence of celiac disease in at-risk and not-at-risk groups... | 2003 | PubMed | 1.7K | ✕ |
Frequently Asked Questions
What is the autoantigen in celiac disease?
Tissue transglutaminase is the autoantigen of celiac disease. "Identification of tissue transglutaminase as the autoantigen of celiac disease" by Dieterich et al. (1997) demonstrated this through identification of antibodies specific to tissue transglutaminase in patient sera. This finding enables serological diagnosis via anti-tissue transglutaminase antibody testing.
How is celiac disease diagnosed in children?
Diagnosis follows ESPGHAN guidelines using serological tests for tissue transglutaminase antibodies and intestinal biopsy confirmation. "European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease" by Husby et al. (2011) updated criteria post-1990, incorporating tissue transglutaminase identification. These guidelines standardize pediatric evaluation to confirm villous atrophy.
What is the prevalence of celiac disease in the US?
Celiac disease prevalence is high in both at-risk and not-at-risk US groups. "Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study" by Fasano et al. (2003) showed it occurs frequently in symptomatic patients, relatives, and those with common disorders without gastrointestinal symptoms. This multicenter study highlights the need for screening beyond symptomatic cases.
What role does gluten play in celiac disease pathology?
Gluten prolamins from wheat, rye, and barley trigger mucosal pathology via major histocompatibility complex associations. "Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue')" by Marsh (1992) identified recurring tetrapeptide motifs in prolamins that drive immune responses. This explains the spectrum of gluten sensitivity observed in celiac disease.
What are current guidelines for celiac disease management?
Management centers on strict gluten avoidance to promote intestinal healing and address deficiencies. "Coeliac Disease" by Holmes and Cooke (1984) outlines foundational approaches to long-term dietary control and monitoring. "Celiac Disease" by Green et al. (2006) details clinical management strategies including nutritional support.
Open Research Questions
- ? How do host-microbe interactions influence genetic risk factors for celiac disease and related inflammatory conditions?
- ? What mutations in FOXP3 contribute to immune dysregulation syndromes overlapping with celiac disease enteropathy?
- ? How can genetic loci identified in type 1 diabetes studies inform celiac disease risk prediction?
- ? What molecular mechanisms link gluten motifs to varying degrees of intestinal histopathology in gluten sensitivity?
Recent Trends
The field maintains 49,793 works with no specified 5-year growth rate available.
Core advancements remain anchored in serological diagnostics from Dieterich et al. and prevalence data from Fasano et al. (2003), with no recent preprints or news reported in the last 12 months.
1997Research Celiac Disease Research and Management with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Celiac Disease Research and Management with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers